×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| SUN PHARMA ADVANCED RESEARCH C | 151 | -795.1 | 149.1 | -2.45 | 4,200 | |
| SEQUENT SCIENTIFIC LTD. | 3966.5 | 64.8 | 3908.1 | 0.13 | 3942 | 262.0 |
| RPG LIFE SCIENCES LTD. | 1760.2 | 349.3 | 1727.1 | 21.12 | 3915 | 41.0 |
Sun Pharma Advanced Research Company Ltd., with Security Code 532872, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.4 | 31.5 | 131.0 | 47.6 | 23.9 | 21.1 | 13.8 | 16.5 | 16.8 | 12.8 |
| Expenses | 106.7 | 94.1 | 114.9 | 137.3 | 126.1 | 112.7 | 116.5 | 124.1 | 111.9 | 116.7 |
| Operating Profit | -78.2 | -62.6 | 16.2 | -89.6 | -102.2 | -91.5 | -102.6 | -107.5 | -95.1 | -103.9 |
| OPM % | -274.77% | -198.48% | 12.34% | -187.82% | -426.64% | -431.87% | -740.4% | -649.28% | -565.85% | -807.54% |
| Other Income | 0.2 | 0.1 | 0.0 | 10.7 | 10.2 | 8.5 | 6.4 | 4.4 | 1.6 | 0.0 |
| Interest | 1.6 | 2.9 | 2.9 | 0.2 | 0.3 | 0.3 | 0.3 | 0.9 | 0.5 | 1.1 |
| Depreciation | 2.7 | 3.0 | 3.1 | 2.9 | 3.1 | 3.2 | 3.2 | 2.7 | 2.8 | 2.8 |
| Profit before tax | -82.4 | -68.4 | 10.2 | -82.0 | -95.4 | -86.4 | -99.7 | -106.7 | -96.8 | -107.7 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -82.4 | -68.4 | 10.2 | -82.0 | -95.4 | -86.4 | -99.7 | -106.7 | -96.8 | -107.7 |
| EPS in Rs | -3.03 | -2.52 | 0.35 | -2.55 | -2.94 | -2.66 | -3.07 | -3.29 | -2.98 | -3.32 |
| Metrics | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|
| Sales | 21.2 | 13.9 | 16.6 | 16.8 | 12.9 | 14.9 |
| Expenses | 112.7 | 116.5 | 122.4 | 110.2 | 115.8 | 88.6 |
| Operating Profit | -91.5 | -102.6 | -105.8 | -93.4 | -102.9 | -73.7 |
| OPM % | -431.9% | -740.4% | -639.1% | -555.4% | -800.2% | -494.2% |
| Other Income | 8.5 | 6.4 | 4.4 | 1.6 | 0.0 | 0.2 |
| Interest | 0.3 | 0.3 | 0.9 | 0.6 | 1.1 | 2.8 |
| Depreciation | 3.2 | 3.2 | 3.1 | 3.1 | 3.2 | 3.1 |
| Profit before tax | -86.4 | -99.7 | -105.4 | -95.5 | -107.2 | -79.4 |
| Tax % | -0% | -0% | -0.4% | -0.4% | -0.1% | -0.1% |
| Net Profit | -86.4 | -99.7 | -105.8 | -95.9 | -107.3 | -79.5 |
| EPS in Rs | -2 | -3 | -3 | -2 | -3 | -2 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -16% |
| 3 Years: | -33% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -4% |
| 3 Years: | -22% |
| 1 Year: | -61% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -4% |
| 3 Years: | -22% |
| 1 Year: | -61% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|